Literature DB >> 26338832

Suppression of Early and Late Afterdepolarizations by Heterozygous Knockout of the Na+/Ca2+ Exchanger in a Murine Model.

Nils Bögeholz1, Paul Pauls2, B Klemens Bauer2, Jan S Schulte2, Dirk G Dechering2, Gerrit Frommeyer2, Uwe Kirchhefer2, Joshua I Goldhaber2, Frank U Müller2, Lars Eckardt2, Christian Pott2.   

Abstract

BACKGROUND: The Na(+)/Ca(2+) exchanger (NCX) has been implied to cause arrhythmias. To date, information on the role of NCX in arrhythmogenesis derived from models with increased NCX expression, hypertrophy, and heart failure. Furthermore, the exact mechanism by which NCX exerts its potentially proarrhythmic effect, ie, by promoting early afterdepolarization (EAD) or delayed afterdepolarization (DAD) or both, is unknown. METHODS AND
RESULTS: We investigated isolated cardiomyocytes from a murine model with heterozygous knockout of NCX (hetKO) using the patch clamp and Ca(2+) imaging techniques. Action potential duration was shorter in hetKO with IKtot not being increased. The rate of spontaneous Ca(2+) release events and the rate of DADs were unaltered; however, DADs had lower amplitude in hetKO. A DAD triggered a spontaneous action potential significantly less often in hetKO when compared with wild-type. The occurrence of EADs was also drastically reduced in hetKO. ICa activity was reduced in hetKO, an effect that was abolished in the presence of the Ca(2+) buffer BAPTA.
CONCLUSIONS: Genetic suppression of NCX reduces both EADs and DADs. The following molecular mechanisms apply: (1) Although the absolute number of DADs is unaffected, an impaired translation of DADs into spontaneous action potentials results from a reduced DAD amplitude. (2) EADs are reduced in absolute number of occurrence, which is presumably a consequence of shortened action potential duration because of reduced NCX activity but also reduced ICa the latter possibly being caused by a direct modulation of Ca(2+)-dependent ICa inhibition by reduced NCX activity. This is the first study to demonstrate that genetic inhibition of NCX protects against afterdepolarizations and to investigate the underlying mechanisms.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  Na+/Ca2+ exchanger; action potentials; arrhythmias, cardiac; heart failure

Mesh:

Substances:

Year:  2015        PMID: 26338832     DOI: 10.1161/CIRCEP.115.002927

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  19 in total

Review 1.  Modulation of the cardiac Na+-Ca2+ exchanger by cytoplasmic protons: Molecular mechanisms and physiological implications.

Authors:  Kyle Scranton; Scott John; Ariel Escobar; Joshua I Goldhaber; Michela Ottolia
Journal:  Cell Calcium       Date:  2019-12-11       Impact factor: 6.817

2.  Triggered activity in atrial myocytes is influenced by Na+/Ca2+ exchanger activity in genetically altered mice.

Authors:  N Bögeholz; P Pauls; S Kaese; J S Schulte; M D Lemoine; D G Dechering; G Frommeyer; J I Goldhaber; M D Seidl; U Kirchhefer; L Eckardt; F U Müller; C Pott
Journal:  J Mol Cell Cardiol       Date:  2016-11-09       Impact factor: 5.000

Review 3.  The Cardiac Na+ -Ca2+ Exchanger: From Structure to Function.

Authors:  Michela Ottolia; Scott John; Adina Hazan; Joshua I Goldhaber
Journal:  Compr Physiol       Date:  2021-12-29       Impact factor: 9.090

4.  Critical Requirements for the Initiation of a Cardiac Arrhythmia in Rat Ventricle: How Many Myocytes?

Authors:  Aman Ullah; Minh Tuan Hoang-Trong; William Jonathan Lederer; Raimond L Winslow; Mohsin Saleet Jafri
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

5.  Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.

Authors:  Lili Wang; Kyungsoo Kim; Shan Parikh; Adrian Gabriel Cadar; Kevin R Bersell; Huan He; Jose R Pinto; Dmytro O Kryshtal; Bjorn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2017-12-05       Impact factor: 5.000

6.  Dyssynchronous calcium removal in heart failure-induced atrial remodeling.

Authors:  F Hohendanner; J DeSantiago; F R Heinzel; L A Blatter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

7.  Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1+/- Mouse Model.

Authors:  Sophie Le Page; Marjorie Niro; Jérémy Fauconnier; Laura Cellier; Sophie Tamareille; Abdallah Gharib; Arnaud Chevrollier; Laurent Loufrani; Céline Grenier; Rima Kamel; Emmanuelle Sarzi; Alain Lacampagne; Michel Ovize; Daniel Henrion; Pascal Reynier; Guy Lenaers; Delphine Mirebeau-Prunier; Fabrice Prunier
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

8.  TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT.

Authors:  Harsha D Devalla; Roselle Gélinas; Elhadi H Aburawi; Abdelaziz Beqqali; Philippe Goyette; Christian Freund; Marie-A Chaix; Rafik Tadros; Hui Jiang; Antony Le Béchec; Jantine J Monshouwer-Kloots; Tom Zwetsloot; Georgios Kosmidis; Frédéric Latour; Azadeh Alikashani; Maaike Hoekstra; Jurg Schlaepfer; Christine L Mummery; Brian Stevenson; Zoltan Kutalik; Antoine Af de Vries; Léna Rivard; Arthur Am Wilde; Mario Talajic; Arie O Verkerk; Lihadh Al-Gazali; John D Rioux; Zahurul A Bhuiyan; Robert Passier
Journal:  EMBO Mol Med       Date:  2016-12-01       Impact factor: 12.137

9.  Characterization of CaV1.2 exon 33 heterozygous knockout mice and negative correlation between Rbfox1 and CaV1.2 exon 33 expressions in human heart failure.

Authors:  Juejin Wang; Guang Li; Dejie Yu; Yuk Peng Wong; Tan Fong Yong; Mui Cheng Liang; Ping Liao; Roger Foo; Uta C Hoppe; Tuck Wah Soong
Journal:  Channels (Austin)       Date:  2018-01-01       Impact factor: 2.581

10.  Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes.

Authors:  J S Schulte; E Fehrmann; M A Tekook; D Kranick; B Fels; N Li; X H T Wehrens; A Heinick; M D Seidl; W Schmitz; F U Müller
Journal:  Basic Res Cardiol       Date:  2016-01-27       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.